Medeon Biodesign Overview
- Founded
-
2012
- Status
-
Public
- Stock Symbol
-
6499
- Investments
-
3
- Share Price
-
$1.95
- (As of Friday Closing)
Medeon Biodesign General Information
Description
Medeon Biodesign Inc develops medical device products. The main services of the Group are the research and development of medical devices, manufacturing, and sale of injection molding and components of medical devices. The company provides products in the fields of cardiovascular and laparoscopic. Its segment includes Medical Device Development Department and Medical Device Components Manufacturing and Sales Department. The majority of the company revenue comes from Medical Device Components Manufacturing and Sales Department segment. The company revenue is mainly derived from USA.
Contact Information
Primary Industry
Surgical Devices
Other Industries
Other Devices and Supplies
Stock Exchange
ROCO
Primary Office
- 116, HouGang Street
- 7th Floor
- Taipei, 111-70
- Taiwan
+886 02 0000 0000
Medeon Biodesign Stock Performance
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.95 | $1.94 | $1.75 - $3.04 | $171M | 87.6M | 311K | -$0.17 |
Medeon Biodesign Financials Summary
|
In Thousands, USD |
TTM 30-Jun-2022 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 | FY 2019 31-Dec-2019 |
|---|---|---|---|---|
| EV | 101,847 | 150,531 | 89,346 | 92,446 |
| Revenue | 8,477 | 2,468 | 4,181 | 14,684 |
| EBITDA | (13,162) | (16,461) | (9,039) | (6,140) |
| Net Income | (14,516) | 74,368 | (6,548) | (8,478) |
| Total Assets | 148,860 | 157,627 | 118,823 | 84,037 |
| Total Debt | 6,460 | 1,092 | 17,666 | 3,951 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Medeon Biodesign Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Medeon Biodesign Patents
Medeon Biodesign Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2017311506-A1 | Suture delivery device for suturing tissue | Active | 11-Aug-2016 | 00000000000 | |
| JP-7007363-B2 | Suture delivery device for suturing tissue | Active | 11-Aug-2016 | 00000000000 | |
| EP-3496627-A1 | Suture delivery device for suturing tissue | Pending | 11-Aug-2016 | 00000000000 | |
| EP-3496627-A4 | Suture delivery device for suturing tissue | Pending | 11-Aug-2016 | 00000000000 | |
| JP-2019524329-A | Suture delivery device for suturing tissue | Active | 11-Aug-2016 | A61B17/0482 |
Medeon Biodesign Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Yue-Teh Jang Ph.D | Founder, Chairman, President & Chief Executive Officer | ||
| Shuling Cheng Ph.D | Chief Strategy Officer |
Medeon Biodesign Board Members (1)
| Name | Representing | Role | Since |
|---|---|---|---|
| Yue-Teh Jang Ph.D | Medeon Biodesign | Founder, Chairman, President & Chief Executive Officer | 000 0000 |
Medeon Biodesign Investments (3)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0000000 (0000 | 08-Jul-2019 | 000000000 | Clinics/Outpatient Services | 000-000 0 | |
| 0000000 00000 | 31-May-2019 | 00000 0000 | Therapeutic Devices | ||
| Panther Orthopedics | 28-Mar-2018 | Corporate | Therapeutic Devices | 000-000 0 |